Life Healthcare Group Limited logo

Life Healthcare Group Limited (0928)

Market Open
13 Aug, 08:00
HKEX HKEX
0. 10
HKD
-0
-0.9901%
HKD
164.69M Market Cap
- P/E Ratio
- Div Yield
2.5M Volume
- Eps
0.1 HKD
Previous Close
Add Transaction
Day Range
0.1 0.1
Year Range
0.06 0.15
Want to track 0928 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming 0928 split of 1:10 in 25 days (8 Sep 2026)

Summary

0928 trading today lower at 0.1 HKD, a decrease of -0.9901% from yesterday's close, completing a monthly increase of 44.9275% or 0.03 HKD. Over the past 12 months, 0928 stock lost -0.9901%.
0928 is not paying dividends to its shareholders.
Life Healthcare Group Limited has a scheduled stock split on Sep 08, 2026 for a 1:10 split ratio, meaning every 0928 investor will receive 1.0 shares for every 10.0 existing shares.
Life Healthcare Group Limited has completed 10 stock splits, with the recent split occurring on Feb 02, 2024.
The company's stock is traded on one exchange.

0928 Chart

People also search for

Changsha Broad Homes Industrial Group Co., Ltd.
0.6 HKD
0%
Xiangxing International Holding Ltd.
0.23 HKD
0%
China Titans Energy Technology Group Co., Ltd.
0.1 HKD
+4.3478%

Life Healthcare Group Limited (0928) FAQ

What is the stock price today?

The current price is 0.10 HKD.

On which exchange is it traded?

Life Healthcare Group Limited is listed on HKEX.

What is its stock symbol?

The ticker symbol is 0928.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 164.69M.

Has Life Healthcare Group Limited ever had a stock split?

Life Healthcare Group Limited had 10 splits and the recent split was on Feb 02, 2024.

Life Healthcare Group Limited Profile

Professional Services Industry
Industrials Sector
Ms. Ming Yan CEO
HKEX Exchange
KYG5924H1231 ISIN
Hong Kong Country
13 Employees
- Last Dividend
8 Sep 2026 Last Split
- IPO Date

Overview

King International Investment Limited, initially established under the name Life Healthcare Group Limited in 2001, has evolved significantly over the years to become a multifaceted investment holding entity with a primary focus on the healthcare sector. Based in North Point, Hong Kong, the company extends its services predominantly within the People's Republic of China and Hong Kong. The strategic rebranding to King International Investment Limited in December 2023 marked a significant milestone in its journey, reflecting its expanded vision and commitments beyond healthcare. Operating through two main segments – Healthcare Products and Services Business, and Money Lending Business – the company has diversified its offerings to encompass a wide range of needs and domains. Beyond its core services in genetic testing and health data analysis which are pivotal in today's data-driven healthcare landscape, it also ventures into money lending activities. This diversification indicates a robust approach to business, identifying and capitalizing on opportunities across different sectors. Additionally, King International Investment Limited offers corporate administrative services alongside its healthcare services, further broadening its scope and reinforcing its role as a comprehensive service provider.

Products and Services

  • Genetic Testing and Health Data Analysis

    At the core of its healthcare segment, King International Investment Limited provides advanced genetic testing and health data analysis services. These services are designed to offer profound insights into an individual's genetic makeup, enabling predictive and personalized healthcare solutions. This advanced approach aids in the early detection of potential health issues, personalized medicine, and the provision of tailored health and wellness strategies.

  • Money Lending Activities

    Expanding its presence into the financial sector, the company also engages in money lending activities. This service offers flexible financial solutions to meet the diverse needs of its clients, providing them with financial support to navigate their personal and business challenges. The money lending arm operates with a commitment to integrity, transparency, and customer-centric policies, ensuring that the solutions provided are both ethical and beneficial to its customers.

  • Corporate Administrative Services

    Complementing its portfolio, King International Investment Limited offers a suite of corporate administrative services. These services are tailored to help businesses streamline their operations, ensuring compliance, efficiency, and optimized management practices. From regulatory compliance to operational support, the company delivers comprehensive solutions that are designed to enhance business performance and sustainability.

  • Healthcare Services

    Beyond genetic testing, the healthcare services provided by King International Investment Limited cover a broad spectrum, including prevention, diagnosis, and treatment support. The company leverages cutting-edge technology and its expertise in the healthcare industry to deliver services that contribute to the overall well-being and health management of individuals and communities.

Contact Information

Address: Gloucester Tower
Phone: -